Cargando…

Novel Potential Biomarkers Associated With Epithelial to Mesenchymal Transition and Bladder Cancer Prognosis Identified by Integrated Bioinformatic Analysis

Bladder cancer (BC) is one of the most common malignancies in terms of incidence and recurrence worldwide. The aim of this study was to identify novel prognostic biomarkers related to BC progression utilizing weighted gene co-expression network analysis (WGCNA) and further bioinformatic analysis. Fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chengyuan, Yang, Yujing, Yin, Lei, Wei, Ningde, Hong, Ting, Sun, Zuyu, Yao, Jiaxi, Li, Zhi, Liu, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338771/ https://www.ncbi.nlm.nih.gov/pubmed/32695668 http://dx.doi.org/10.3389/fonc.2020.00931

Ejemplares similares

Identification of prognostic chromatin-remodeling genes in clear cell renal cell carcinoma
por: Yang, Yujing, et al.
Publicado: (2020)

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)

Analysis of Epithelial-Mesenchymal Transition Metabolism Identifies Possible Cancer Biomarkers Useful in Diverse Genetic Backgrounds
por: Matadamas-Guzman, Meztli, et al.
Publicado: (2020)

Bioinformatics and pathway enrichment analysis identified hub genes and potential biomarker for gastric cancer prognosis
por: Darang, Elham, et al.
Publicado: (2023)

MACC1 Is Associated With Epithelial–Mesenchymal Transition and Can Predict Poor Prognosis in Nasopharyngeal Carcinoma
por: Cheng, Hao, et al.
Publicado: (2021)

The crosstalk between anoikis and epithelial-mesenchymal transition and their synergistic roles in predicting prognosis in colon adenocarcinoma
por: Zhou, Jiahui, et al.
Publicado: (2023)

Epithelial–Mesenchymal Transition in Ovarian Carcinoma
por: Davidson, Ben, et al.
Publicado: (2012)

Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis
por: Wang, Yejinpeng, et al.
Publicado: (2019)

Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer
por: Liu, Yiming, et al.
Publicado: (2021)

Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy
por: Zhang, Si-yuan, et al.
Publicado: (2021)

Exosomes Regulate the Epithelial–Mesenchymal Transition in Cancer
por: Jiang, Jingwen, et al.
Publicado: (2022)

The Epithelial to Mesenchymal Transition Related Gene Calumenin Is an Adverse Prognostic Factor of Bladder Cancer Correlated With Tumor Microenvironment Remodeling, Gene Mutation, and Ferroptosis
por: Du, YiHeng, et al.
Publicado: (2021)

Corrigendum: The epithelial to mesenchymal transition related gene calumenin is an adverse prognostic factor of bladder cancer correlated with tumor microenvironment remodeling, gene mutation, and ferroptosis
por: Du, YiHeng, et al.
Publicado: (2023)

The Emerging Role of Exosomes in Epithelial–Mesenchymal-Transition in Cancer
por: Vella, Laura Jayne
Publicado: (2014)

Role of the Epithelial-Mesenchymal Transition in Bladder Cancer: From Prognosis to Therapeutic Target
por: Yun, Seok Joong, et al.
Publicado: (2013)

Identification of Epithelial–Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma
por: Zhong, Weimin, et al.
Publicado: (2020)

Editorial: Identifying novel biomarkers in bladder cancer
por: Ecke, Thorsten H., et al.
Publicado: (2023)

Gene Expression Profiles Identified Novel Urine Biomarkers for Diagnosis and Prognosis of High-Grade Bladder Urothelial Carcinoma
por: Song, Yuxuan, et al.
Publicado: (2020)

PIK3CA Is Regulated by CUX1, Promotes Cell Growth and Metastasis in Bladder Cancer via Activating Epithelial-Mesenchymal Transition
por: Wang, Zhongyu, et al.
Publicado: (2020)

Tumor Budding as a Marker for Poor Prognosis and Epithelial–Mesenchymal Transition in Lung Cancer: A Systematic Review and Meta-Analysis
por: Thakur, Nishant, et al.
Publicado: (2022)

Role of Glycans in Cancer Cells Undergoing Epithelial–Mesenchymal Transition
por: Li, Xiang, et al.
Publicado: (2016)

Crosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition
por: Lindsey, Stephan, et al.
Publicado: (2014)

Epithelial to mesenchymal transition in tumor cells as consequence of phenotypic instability
por: García de Herreros, Antonio
Publicado: (2014)

Effects of Epithelial to Mesenchymal Transition on T Cell Targeting of Melanoma Cells
por: Woods, Katherine, et al.
Publicado: (2014)

Role of LncRNAs in the Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
por: Ge, Xiaoyong, et al.
Publicado: (2021)

Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies
por: Qiao, Lili, et al.
Publicado: (2022)

Epithelial-Mesenchymal Transition and Its Regulation Mechanisms in Pancreatic Cancer
por: Luu, Tuan
Publicado: (2021)

Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor
por: Li, Xiaoxiao, et al.
Publicado: (2022)

Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer
por: Gelissen, Julia H., et al.
Publicado: (2022)

Editorial: Molecular mechanisms of epithelial-mesenchymal transition in cancer metastasis
por: Amin, Amr, et al.
Publicado: (2022)

Advances in the relationship between ferroptosis and epithelial–mesenchymal transition in cancer
por: Mu, Wenrong, et al.
Publicado: (2023)

Prognostic biomarker MCP-4 triggers epithelial-mesenchymal transition via the p38 MAPK pathway in ovarian cancer
por: Li, Siting, et al.
Publicado: (2022)

An epithelial–mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition?
por: da Fonseca, Leonardo Marques, et al.
Publicado: (2016)

Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors
por: Morandi, Andrea, et al.
Publicado: (2017)

Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer
por: Zhong, Weilong, et al.
Publicado: (2023)

Identification of epithelial-mesenchymal transition-related biomarkers in lung adenocarcinoma using bioinformatics and lab experiments
por: Cheng, Yuanjun, et al.
Publicado: (2023)

Identifying novel biomarkers associated with bladder cancer treatment outcomes
por: Castaneda, Peris R., et al.
Publicado: (2023)

An epithelial–mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer
por: Tong, Hang, et al.
Publicado: (2021)

Effect of unfolded protein response on the immune infiltration and prognosis of transitional cell bladder cancer
por: Yan, Xiaokai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_64hmq598prtgearhef7mkhhbak